Skip to main content
Clinical Trials/NCT04483518
NCT04483518
Completed
Not Applicable

Epidemiological Survey of Hepatitis D Virus Infection in Hepatitis B Population Among Multi-center Hepatitis B Population in China

The First Hospital of Jilin University1 site in 1 country5,000 target enrollmentStarted: June 3, 2019Last updated:

Overview

Phase
Not Applicable
Status
Completed
Enrollment
5,000
Locations
1
Primary Endpoint
The prevalence of hepatitis D virus

Overview

Brief Summary

This cross-sectional study will screen out hepatitis D virus-infected patients in HBsAg-positive people. Observe and describe the prevalence of hepatitis D infection among HBsAg positive people. The provinces of China are divided into 5 geographical areas (North, South, East, West and Central) to recruit patients according to the population density of each area. After statistical calculation, the total number of population needed is 3808.

Detailed Description

Entry criteria:1. Age 18 years and above. 2. male or female. 3. Diagnosed as chronic HBV infection (HBsAg positive) 4.Ability to sign informed consent.

Exclusion criteria:Patients who disagree to participate in the trial.

After the informed consent was signed, the quantitative data of the previous surface antigen or HBV DNA titer was collected during the return visit. 4 ml of venous blood was collected on the same day or the remaining serum from the surface antigen or hepatitis B quantitative test was collected for the detection of hepatitis D antibody and/or the quantitative detection of hepatitis D RNA.

After statistical analysis, calculate the hepatitis D infection status in China.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
16 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Hepatitis B surface antigen or HBV DNA positive

Exclusion Criteria

  • Can't sign informed consent

Outcomes

Primary Outcomes

The prevalence of hepatitis D virus

Time Frame: 2019-2020

Proportion of hepatitis D infection in people with hepatitis B infection

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Junqi Niu

Director of the department of Hepatology

The First Hospital of Jilin University

Study Sites (1)

Loading locations...

Similar Trials